Inside the research
Morgan Stanley
MS Research profile · latest available data
Price overview
$196.31
▼ -0.01 (-0.0%)
| 52w hi | $227.30 |
|---|---|
| 52w lo | $148.49 |
| Vol | 4.53M |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.20
| Short | +0.07 |
|---|---|
| Medium | +0.22 |
| Long | +0.40 |
computed 2026-09-27
Key fundamentals
Morgan Stanley
Financial Services · Capital Markets
| Market cap | $308.32B |
|---|---|
| Enterprise value | $187.60B |
| Trailing P/E | 15.84x |
| Forward P/E | 14.42x |
| P / S (ttm) | 3.96x |
| Profit margin | 25.9% |
| Return on equity | 18.0% |
| Revenue growth | +28.0% |
| Earnings growth | +62.4% |
| Debt / equity | 517.28 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.36 | |
| Sector | +0.02 | |
| Technical | +0.06 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Asia, Europe, the Middle East, and Africa. It operates through Institutional Securities, Wealth Management, and Investment Management segments. The company offers capital raising and financial advisory services, including services related to the underwriting of debt, equity securities, and other products, as well as advice on mergers and acquisitions, restructurings, and project finance. It also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services; Asia wealth management; business-related investments services; originating corporate and commercial real estate loans, secured lending facilities, and extending securities-based and other financing; and research activities. In addition, the company offers financial advisor-led brokerage, investment advisory, custody, cash management, and administrative services; self-directed brokerage services; financial and wealth planning services; stock plan administration; securities-based lending, residential real estate loans, and other lending products; banking; and retirement plan services. Further, it provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals. Morgan Stanley was founded in 1924 and is headquartered in New York, New York.
Risk Metrics
| Beta vs SPX | 1.40 |
|---|---|
| Corr SPX | 0.73 |
| Annual vol | 30.8% |
| Annual ret | +37.2% |
| Sharpe | 1.21 |
| Max DD | -29.2% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $203.29 |
|---|---|
| High / Low | $230.00 / $165.00 |
| Median | $205.00 |
| Analysts | 21 |
| Strong Buy | 2 | |
|---|---|---|
| Buy | 8 | |
| Hold | 14 | |
| Sell | 0 | |
| Strong Sell | 1 |
Recent rating actions
| 2026-05-08 | Citigroup | → Neutral |
| 2026-04-16 | Wells Fargo | → Equal-Weight |
| 2026-04-16 | RBC Capital | → Sector Perform |
| 2026-04-16 | Keefe, Bruyette & Woods | → Outperform |
| 2026-04-16 | Goldman Sachs | → Neutral |
| 2026-04-16 | Citizens | → Market Perform |
Officers & Board
| CEO | Ted Pick since 2024 |
|---|---|
| Director | Masato Miyachi since 2022 |
| Director | Erika H. James since 2022 |
| Director | Hiro Kamezawa since 2021 |
| Director | Shelley Leibowitz since 2020 |
| Director | Stephen J. Luczo since 2019 |
| Director | Mary Lovelace Schapiro since 2018 |
| Director | Dennis M. Nally since 2016 |
| Director | Alistair Darling since 2016 |
| Director | Perry M. Traquina since 2015 |
| Director | Jami Miscik since 2014 |
| Director | Tom Glocer since 2013 |
| Director | Ray Wilkins since 2013 |
| Director | Robert Herz since 2012 |
| Director | James P. Gorman since 2010 |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-15 | Earnings Release, Exhibits | read |
| 2026-06-24 | Other Material Event, Exhibits | read |
| 2026-05-15 | Shareholder Vote | read |
| 2026-04-15 | Earnings Release, Exhibits | read |
| 2026-02-11 | Other Material Event | read |
| 2026-01-15 | Earnings Release, Reg FD Disclosure… | read |
| 2025-10-15 | Earnings Release, Exhibits | read |
| 2025-09-30 | Other Material Event, Exhibits | read |
| 2025-09-23 | Other Material Event, Exhibits | read |
| 2025-07-16 | Earnings Release, Exhibits | read |
| 2025-07-01 | Other Material Event, Exhibits | read |
| 2025-06-16 | Officer / Director Change, Exhibits | read |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 8 |
| Top-5 share | 99.3% |
| HHI | 5,103 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $20.81B | 99.56M |
| Fidelity / FMR LLC | $5.21B | 24.90M |
| Capital Research / Capital World | $2.81B | 13.45M |
| Citadel Advisors | $1.04B | 5.00M |
| Millennium Management | $251.65M | 1.20M |
| AQR Capital Management | $191.38M | 915.53K |
| T. Rowe Price Group | $4.02M | 19.25M |
| Bridgewater Associates | $3.92M | 18.73K |
As of 2026-06-30
Connections
Dividends
| Yield (TTM) | 1.53% |
|---|---|
| $ / share (TTM) | $3.00 |
| 5y CAGR | +22.4% |
Annual dividend per share
| 2021 | $2.10 |
|---|---|
| 2022 | $2.95 |
| 2023 | $3.25 |
| 2024 | $3.55 |
| 2025 | $3.85 |
| 2026 | $2.00 |
SEC Filings
The Long Run
FY 2009–2025 · 17 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $8.61B | -21.0% | |
| Net income | $9.09B | +6.7% | |
| Cash from ops | -$17.89B | +46.2% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $197.98 | $197.98 | $194.25 | $196.31 | 4.53M |
| Sep 24 | $197.40 | $198.30 | $194.75 | $196.32 | 5.20M |
| Sep 23 | $198.50 | $201.12 | $197.94 | $198.39 | 4.34M |
| Sep 22 | $205.57 | $206.75 | $198.21 | $200.18 | 7.80M |
| Sep 21 | $205.49 | $206.66 | $203.18 | $206.12 | 4.04M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →